Novartis Reporting System and Materiality. 1.3.1 Financial information is obtained from the Financial Consolidation & Reporting System of Novartis and the supporting general ledgers are prepared in accordance with Novartis’s Accounting Manual (the “NAM”). The Financial Consolidation & Reporting System is the system of record for Novartis external reporting. References in the Novartis Statement of Net Assets included as Part 2 of this Schedule 18 shown as “BS01 lines 010-671” relate to the groupings shown in Novartis’s monthly reporting form “BS01 – Balance sheet”.
Appears in 3 contracts
Samples: Contribution Agreement, Contribution Agreement (Glaxosmithkline PLC), Contribution Agreement (Glaxosmithkline PLC)
Novartis Reporting System and Materiality. 1.3.1 Financial information is obtained from the Financial Consolidation & Reporting System of Novartis and the supporting general ledgers are prepared in accordance with Novartis’s Accounting Manual (the “NAM”). The Financial Consolidation & Reporting System is the system of record for Novartis external reporting. References in the Novartis Statement of Net Assets included as Part 2 of this Schedule 18 shown as “BS01 lines 010-671” relate to the groupings shown in Novartis’s monthly reporting form “BS01 – — Balance sheet”.
Appears in 2 contracts
Samples: Contribution Agreement (Novartis Ag), Contribution Agreement (Novartis Ag)
Novartis Reporting System and Materiality. 1.3.1 Financial information is obtained from the Financial Consolidation & Reporting System of Novartis and the supporting general ledgers are prepared in accordance with Novartis’s ’ Accounting Manual (the “NAM”). The Financial Consolidation & Reporting System is the system of record for Novartis external reporting. References in the Novartis Statement of Net Assets included as Part part 2 of this Schedule 18 23 shown as “BS01 lines 010-671” relate to the groupings shown in Novartis’s ’ monthly reporting form “BS01 – Balance sheet”.
Appears in 2 contracts
Samples: Share and Business Sale Agreement (Glaxosmithkline PLC), Share and Business Sale Agreement (Glaxosmithkline PLC)
Novartis Reporting System and Materiality. 1.3.1 Financial information is obtained from the Financial Consolidation & Reporting System of Novartis and the supporting general ledgers are prepared in accordance with Novartis’s ’ Accounting Manual (the “NAM”). The Financial Consolidation & Reporting System is the system of record for Novartis external reporting. References in the Novartis Statement of Net Assets included as Part part 2 of this Schedule 18 23 shown as “BS01 lines 010-671” relate to the groupings shown in Novartis’s ’ monthly reporting form “BS01 – — Balance sheet”.
Appears in 1 contract
